| Dr Samuel F Jirik, DDS, PA | |
|
606 W Main St, Cabot, AR 72023-2423 | |
| (501) 843-9561 | |
| (501) 843-5971 |
| Full Name | Dr Samuel F Jirik |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 606 W Main St, Cabot, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114076759 | NPI | - | NPPES |
| 2741 | Other | AR | STATE LICENSE |
| 59168 | Other | AR | BCBS PROVIDER |
| 625384 | Other | AR | UNITED CONCORDIA PROVIDER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | AR2741 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samuel F Jirik, DDS, PA 606 W Main St, P.o. Box 1115, Cabot, AR 72023-2423 Ph: (501) 843-9561 | Dr Samuel F Jirik, DDS, PA 606 W Main St, Cabot, AR 72023-2423 Ph: (501) 843-9561 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.
Cancer patients treated with the chemotherapy agent bevacizumab (Avastin) may be at an increased risk of severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment. This conclusion stems from a study of more than 12,000 patients by Shenhong Wu, M.D., Ph.D., Principal Investigator, and colleagues at Stony Brook University Medical Center. Their findings are reported in online June 10 in the Journal of the American Society Nephrology (JASN).
People who are confident, comfortable and flexible with their eating habits may be at a significantly lower risk of cardiovascular disease than people who are not.
Scientists at The Scripps Research Institute have shown how to synthesize in the laboratory an important set of natural compounds known as terpenes. The largest class of chemicals made by living organisms, terpenes are made within cells by some of the most complex chemical reactions found in biology.
Thiazolidinediones are a class of medications that are commonly prescribed to treat type-2 diabetes, while fibrates are a structurally-related class of medications that are prescribed to modulate lipid levels in both diabetic and non-diabetic patients to help reduce the risk of cardiovascular disease.
› Verified 9 days ago
Dr. Zaquiary Patrick Williford, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 112 S Rockwood Dr Ste A, Cabot, AR 72023 Phone: 501-628-9501 | |
Dr. Ashley L Fields, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 24 Spring St, Suite B, Cabot, AR 72023 Phone: 501-941-5439 Fax: 501-941-2453 | |
Dr. James D. Burleson, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 3284 Highway 367 S, Cabot, AR 72023 Phone: 501-843-5808 Fax: 501-941-3572 | |
Dr. John Bradley Burleson, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 3284 Highway 367 S, Cabot, AR 72023 Phone: 501-843-5808 Fax: 501-941-3572 | |
Dr. Matthew W Dover, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 108 S 10th St, Cabot, AR 72023 Phone: 501-843-7726 Fax: 501-843-3561 | |
Dr. David J Glover, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 12 Marlou Dr, Cabot, AR 72023 Phone: 501-628-5555 Fax: 501-628-5562 |